Best Practices for Submission of NMR Data to Support Higher Order Structure Assessment of Generic Peptide Drugs

Kang Chen1, Cameron J Smith2

  • 1Division of Complex Drug Analysis, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, 20993, USA. kang.chen@fda.hhs.gov.

The AAPS Journal
|January 20, 2023
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos